Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Industry News
FDA Warns Hospira Again, This Time in India
Beleaguered Hospira has received an FDA warning letter following an inspection at the companys India plant
June 5, 2013
Add Us On Google
Hospira has received another warning letter from the US FDA following an inspection at the company’s India plant in October 2012. Read the
full story
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
2026 AI Trends in Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
Foreign CMOs accelerate US investments in regionalization push: GlobalData
Continuous upstream bioprocessing makes headway in biomanufacturing
Biopharma is expecting much of CDMOs, but are they up to the challenge?
Sponsored Picks
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored
2026 Manufacturing Medical Device Trends for Life Sciences
Load More Content